ArticleBMC microbiology2026
Bioprocessing of Talaromyces purpurogenus for production of dihydromonascorubrin with a powerful antioxidant and antimicrobial activities integrated with the network-guided target prediction and molecular docking analyses.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The antibiotic resistance of pathogenic microorganisms due to the irresponsible use in healthcare and agricultural practices is one of the global threats for the human, especially immune-compromised patients. Thus, searching for a novel compounds from fungi with unique affinity to combat the drug-resistant microorganisms was the objective. Talaromyces purpurogenus # PZ292970.1, an endophyte of palm tree Elaeis guineensis, has the highest productivity of azaphilone pigment (25.5 AU410/ml), with a strong activity against E. coli (MIC value 6.8 µg/ml), S. aureus and C. albicans (MIC value 12.5 µg/ml). The extracted pigment of T. purpurogenus has a strong antibiofilm activity for S. aureus (86.2%), C. albicans (85.8%) and E. coli (79.7%), compared to the control. The TLC purified-pigment of T. purpurogenus had a maximum absorbance at λ
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.